An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P
- PMID: 1714596
- PMCID: PMC52271
- DOI: 10.1073/pnas.88.16.7247
An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P
Abstract
Deposition of the beta-amyloid protein in senile plaques is a pathologic hallmark of Alzheimer disease (AD). Focal deposition of beta amyloid in the adult rat cerebral cortex caused profound neurodegenerative changes, including neuronal loss and degenerating neurons and neurites. Chronic induction of the Alz-50 antigen appeared in neurons around focal cortical deposits of beta amyloid. Immunoblot analysis showed that beta amyloid induced Alz-50-immunoreactive proteins in rat cerebral cortex that were very similar to the proteins induced in human cerebral cortex from patients with AD. The neuropeptide substance P prevented beta-amyloid-induced neuronal loss and expression of Alz-50 proteins when coadministered into the cerebral cortex. Systemic administration of substance P also provided protection against the effects of intracerebral beta amyloid. Thus, beta amyloid is a potent neurotoxin in the adult brain in vivo, and its effects can be blocked by substance P.
Similar articles
-
Evidence that transmitter-containing dystrophic neurites precede those containing paired helical filaments within senile plaques in the entorhinal cortex of nondemented elderly and Alzheimer's disease patients.Brain Res. 1993 Aug 13;619(1-2):55-68. doi: 10.1016/0006-8993(93)91595-j. Brain Res. 1993. PMID: 7690677
-
Amyloid beta protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid beta protein.Brain Res. 1994 Mar 14;639(2):240-4. doi: 10.1016/0006-8993(94)91736-1. Brain Res. 1994. PMID: 7515762
-
In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment.Neurobiol Aging. 1992 Sep-Oct;13(5):537-42. doi: 10.1016/0197-4580(92)90053-z. Neurobiol Aging. 1992. PMID: 1461341
-
Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.J Comp Neurol. 1993 Aug 8;334(2):176-91. doi: 10.1002/cne.903340203. J Comp Neurol. 1993. PMID: 7690048
-
[Alzheimer disease. Role of beta A4 peptide and cerebral amyloid substance].Presse Med. 1994 May 14;23(18):848-54. Presse Med. 1994. PMID: 7937606 Review. French.
Cited by
-
Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease.Front Cell Neurosci. 2015 May 26;9:191. doi: 10.3389/fncel.2015.00191. eCollection 2015. Front Cell Neurosci. 2015. PMID: 26074767 Free PMC article. Review.
-
Neuropathological changes in brain cortex and hippocampus in a rat model of Alzheimer's disease.Iran Biomed J. 2011;15(1-2):51-8. Iran Biomed J. 2011. PMID: 21725500 Free PMC article.
-
A femtomolar-acting neuroprotective peptide.J Clin Invest. 1996 May 15;97(10):2299-307. doi: 10.1172/JCI118672. J Clin Invest. 1996. PMID: 8636410 Free PMC article.
-
BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice.Neurobiol Dis. 2007 Apr;26(1):134-45. doi: 10.1016/j.nbd.2006.12.008. Epub 2006 Dec 20. Neurobiol Dis. 2007. PMID: 17258906 Free PMC article.
-
Neuronal and axonal loss are selectively linked to fibrillar amyloid-{beta} within plaques of the aged primate cerebral cortex.Am J Pathol. 2010 Jul;177(1):325-33. doi: 10.2353/ajpath.2010.090937. Epub 2010 May 20. Am J Pathol. 2010. PMID: 20489158 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources